Oman Clot Management Devices Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030
Description
Oman Clot Management Devices Market Overview
The Oman Clot Management Devices Market is valued at USD 12 million, based on a five-year historical analysis and Oman’s share within the broader Middle East and Africa clot management devices market and local anticoagulant spending trends. This growth is primarily driven by the increasing prevalence of cardiovascular diseases and venous thromboembolism, rising incidence of stroke, growing burden of diabetes and obesity, and the expansion of healthcare infrastructure in the region. The demand for innovative clot management solutions is further fueled by technological advancements in minimally invasive thrombectomy systems, aspiration and infusion catheters, and vena cava filters, as well as greater clinician preference for device-based clot removal to improve outcomes and shorten hospital stays. Muscat, the capital city, along with other major cities like Salalah and Sohar, dominate the Oman Clot Management Devices Market due to their well-established secondary and tertiary care hospitals and access to advanced medical technologies. The concentration of specialized cardiac, interventional radiology, and neurovascular services in these urban areas enhances the availability and adoption of clot management devices, supported by ongoing investments in cath labs, stroke-ready centers, and critical care capacity, thereby contributing to market growth. Device registration, importation, and use of thrombectomy systems, catheters, and vascular filters in Oman are governed by the Medical Devices and Supplies Regulation issued by the Ministry of Health (now Ministry of Health and Sultanate of Oman’s unified procurement structures) under Ministerial Decision No. 41/2019, which sets requirements for classification, registration, quality, and post?market surveillance of medical devices. This framework requires that advanced clot management devices placed in tertiary care and specialized centers comply with recognized standards (including CE marking or equivalent), be registered with the Directorate General of Pharmaceutical Affairs & Drug Control, and meet vigilance and incident?reporting obligations, supporting safer adoption and consistent quality across public and private hospitals.
Oman Clot Management Devices Market Segmentation
By Product: The product segmentation of the Oman Clot Management Devices Market includes various types of devices designed for effective clot management. The key subsegments are Peripheral Thrombectomy Devices, Neurovascular Thrombectomy Devices, Aspiration Catheters, Infusion Catheters, Inferior Vena Cava (IVC) Filters, Hemodialysis & AV Access Thrombectomy Devices, and Accessories and Guidewires. Among these, Peripheral Thrombectomy Devices are leading the market due to their widespread application in treating deep vein thrombosis, pulmonary embolism, and other peripheral vascular conditions, particularly as minimally invasive mechanical thrombectomy gains preference over systemic thrombolysis for selected patients. The increasing incidence of these conditions, coupled with advancements in device technology such as large?bore aspiration systems, rotational and rheolytic thrombectomy platforms, and improved trackability of catheters, has significantly boosted the demand for these devices. By End-User: The end-user segmentation of the Oman Clot Management Devices Market includes Tertiary Care Hospitals, Specialized Cardiac Centers, Specialized Neurovascular Centers, Ambulatory Surgical Centers, and Others. Tertiary Care Hospitals are the leading end-users due to their comprehensive services, interventional radiology and cardiology suites, intensive care capacity, and advanced treatment capabilities. These facilities are equipped with the latest imaging technologies, catheterization laboratories, and skilled multidisciplinary teams, making them the preferred choice for patients requiring complex clot management procedures such as pulmonary embolism thrombectomy, limb ischemia interventions, and endovascular stroke treatment. The increasing number of patients seeking treatment in these hospitals, supported by national strategies to strengthen noncommunicable disease and stroke care pathways, is driving the demand for clot management devices.
Oman Clot Management Devices Market Competitive Landscape
The Oman Clot Management Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Johnson & Johnson (Cerenovus), Penumbra, Inc., Stryker Corporation, Teleflex Incorporated, AngioDynamics, Inc., Merit Medical Systems, Inc., Cook Medical LLC, Terumo Corporation, Cordis, Philips Image Guided Therapy (Philips Healthcare), Acandis GmbH, MicroPort Scientific Corporation contribute to innovation, geographic expansion, and service delivery in this space.
Medtronic plc
1949 Dublin, Ireland
Boston Scientific Corporation
1979 Marlborough, Massachusetts, USA
Abbott Laboratories
1888 Abbott Park, Illinois, USA
Johnson & Johnson (Cerenovus)
1886 New Brunswick, New Jersey, USA
Penumbra, Inc. 2004 Alameda, California, USA
Company
Establishment Year
Headquarters
Global Clot Management Devices Revenue (USD Million)
Middle East & Africa Revenue Share (%)
Estimated Oman Revenue Share in MEA (%)
3-Year CAGR in Clot Management Segment (%)
Number of Clot Management SKUs Marketed in Oman
Depth of Portfolio (Neuro, Peripheral, Coronary Coverage)
Oman Clot Management Devices Market Industry Analysis
Growth Drivers
Increasing Prevalence of Cardiovascular Diseases: The prevalence of cardiovascular diseases in Oman is rising, with approximately 30% of the adult population affected, according to the World Health Organization. This increase is attributed to lifestyle changes and an aging population. The Omani Ministry of Health reported that cardiovascular diseases accounted for around 40% of total deaths, highlighting the urgent need for effective clot management devices to address this growing health crisis. Advancements in Medical Technology: The Oman healthcare sector is witnessing significant advancements in medical technology, with investments reaching OMR 250 million in future. Innovations in clot management devices, such as improved stents and thrombectomy tools, are enhancing treatment outcomes. The integration of cutting-edge technologies is expected to improve patient recovery times and reduce hospital stays, thereby driving demand for these devices in the market. Government Initiatives for Healthcare Improvement: The Omani government has launched several initiatives aimed at improving healthcare infrastructure, with a budget allocation of OMR 2 billion for health services in future. These initiatives include the establishment of specialized cardiac care centers and training programs for healthcare professionals. Such efforts are expected to enhance the availability and adoption of advanced clot management devices, ultimately benefiting patient care and outcomes.
Market Challenges
High Cost of Advanced Devices: The high cost of advanced clot management devices poses a significant challenge in Oman, where healthcare spending per capita is approximately OMR 600. Many hospitals face budget constraints, limiting their ability to procure the latest technologies. This financial barrier can hinder the adoption of innovative devices, impacting patient access to effective treatment options and overall market growth. Limited Awareness Among Healthcare Professionals: There is a notable lack of awareness regarding the latest clot management technologies among healthcare professionals in Oman. A survey conducted in future indicated that only 50% of healthcare providers were familiar with the newest devices available. This knowledge gap can lead to underutilization of advanced treatment options, ultimately affecting patient outcomes and the overall effectiveness of the healthcare system.
Oman Clot Management Devices Market Future Outlook
The future of the Oman clot management devices market appears promising, driven by ongoing technological advancements and government support for healthcare improvements. As the healthcare infrastructure expands, the demand for innovative and effective treatment options is expected to rise. Additionally, the integration of artificial intelligence in medical devices is likely to enhance diagnostic accuracy and treatment efficacy, further propelling market growth. The focus on patient-centric care will also shape future developments in this sector.
Market Opportunities
Growing Demand for Minimally Invasive Procedures: There is an increasing demand for minimally invasive procedures in Oman, with a projected growth rate of 20% annually. This trend is driven by patient preferences for less invasive options that offer quicker recovery times. As a result, manufacturers of clot management devices have a significant opportunity to develop and market products that cater to this demand, enhancing patient satisfaction and outcomes. Expansion of Healthcare Infrastructure: The ongoing expansion of healthcare infrastructure in Oman, with over 15 new hospitals planned by future, presents a substantial opportunity for the clot management devices market. This growth will facilitate increased access to advanced medical technologies and improve patient care. Companies that strategically position themselves in this expanding market can capitalize on the rising demand for effective clot management solutions.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
The Oman Clot Management Devices Market is valued at USD 12 million, based on a five-year historical analysis and Oman’s share within the broader Middle East and Africa clot management devices market and local anticoagulant spending trends. This growth is primarily driven by the increasing prevalence of cardiovascular diseases and venous thromboembolism, rising incidence of stroke, growing burden of diabetes and obesity, and the expansion of healthcare infrastructure in the region. The demand for innovative clot management solutions is further fueled by technological advancements in minimally invasive thrombectomy systems, aspiration and infusion catheters, and vena cava filters, as well as greater clinician preference for device-based clot removal to improve outcomes and shorten hospital stays. Muscat, the capital city, along with other major cities like Salalah and Sohar, dominate the Oman Clot Management Devices Market due to their well-established secondary and tertiary care hospitals and access to advanced medical technologies. The concentration of specialized cardiac, interventional radiology, and neurovascular services in these urban areas enhances the availability and adoption of clot management devices, supported by ongoing investments in cath labs, stroke-ready centers, and critical care capacity, thereby contributing to market growth. Device registration, importation, and use of thrombectomy systems, catheters, and vascular filters in Oman are governed by the Medical Devices and Supplies Regulation issued by the Ministry of Health (now Ministry of Health and Sultanate of Oman’s unified procurement structures) under Ministerial Decision No. 41/2019, which sets requirements for classification, registration, quality, and post?market surveillance of medical devices. This framework requires that advanced clot management devices placed in tertiary care and specialized centers comply with recognized standards (including CE marking or equivalent), be registered with the Directorate General of Pharmaceutical Affairs & Drug Control, and meet vigilance and incident?reporting obligations, supporting safer adoption and consistent quality across public and private hospitals.
Oman Clot Management Devices Market Segmentation
By Product: The product segmentation of the Oman Clot Management Devices Market includes various types of devices designed for effective clot management. The key subsegments are Peripheral Thrombectomy Devices, Neurovascular Thrombectomy Devices, Aspiration Catheters, Infusion Catheters, Inferior Vena Cava (IVC) Filters, Hemodialysis & AV Access Thrombectomy Devices, and Accessories and Guidewires. Among these, Peripheral Thrombectomy Devices are leading the market due to their widespread application in treating deep vein thrombosis, pulmonary embolism, and other peripheral vascular conditions, particularly as minimally invasive mechanical thrombectomy gains preference over systemic thrombolysis for selected patients. The increasing incidence of these conditions, coupled with advancements in device technology such as large?bore aspiration systems, rotational and rheolytic thrombectomy platforms, and improved trackability of catheters, has significantly boosted the demand for these devices. By End-User: The end-user segmentation of the Oman Clot Management Devices Market includes Tertiary Care Hospitals, Specialized Cardiac Centers, Specialized Neurovascular Centers, Ambulatory Surgical Centers, and Others. Tertiary Care Hospitals are the leading end-users due to their comprehensive services, interventional radiology and cardiology suites, intensive care capacity, and advanced treatment capabilities. These facilities are equipped with the latest imaging technologies, catheterization laboratories, and skilled multidisciplinary teams, making them the preferred choice for patients requiring complex clot management procedures such as pulmonary embolism thrombectomy, limb ischemia interventions, and endovascular stroke treatment. The increasing number of patients seeking treatment in these hospitals, supported by national strategies to strengthen noncommunicable disease and stroke care pathways, is driving the demand for clot management devices.
Oman Clot Management Devices Market Competitive Landscape
The Oman Clot Management Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Johnson & Johnson (Cerenovus), Penumbra, Inc., Stryker Corporation, Teleflex Incorporated, AngioDynamics, Inc., Merit Medical Systems, Inc., Cook Medical LLC, Terumo Corporation, Cordis, Philips Image Guided Therapy (Philips Healthcare), Acandis GmbH, MicroPort Scientific Corporation contribute to innovation, geographic expansion, and service delivery in this space.
Medtronic plc
1949 Dublin, Ireland
Boston Scientific Corporation
1979 Marlborough, Massachusetts, USA
Abbott Laboratories
1888 Abbott Park, Illinois, USA
Johnson & Johnson (Cerenovus)
1886 New Brunswick, New Jersey, USA
Penumbra, Inc. 2004 Alameda, California, USA
Company
Establishment Year
Headquarters
Global Clot Management Devices Revenue (USD Million)
Middle East & Africa Revenue Share (%)
Estimated Oman Revenue Share in MEA (%)
3-Year CAGR in Clot Management Segment (%)
Number of Clot Management SKUs Marketed in Oman
Depth of Portfolio (Neuro, Peripheral, Coronary Coverage)
Oman Clot Management Devices Market Industry Analysis
Growth Drivers
Increasing Prevalence of Cardiovascular Diseases: The prevalence of cardiovascular diseases in Oman is rising, with approximately 30% of the adult population affected, according to the World Health Organization. This increase is attributed to lifestyle changes and an aging population. The Omani Ministry of Health reported that cardiovascular diseases accounted for around 40% of total deaths, highlighting the urgent need for effective clot management devices to address this growing health crisis. Advancements in Medical Technology: The Oman healthcare sector is witnessing significant advancements in medical technology, with investments reaching OMR 250 million in future. Innovations in clot management devices, such as improved stents and thrombectomy tools, are enhancing treatment outcomes. The integration of cutting-edge technologies is expected to improve patient recovery times and reduce hospital stays, thereby driving demand for these devices in the market. Government Initiatives for Healthcare Improvement: The Omani government has launched several initiatives aimed at improving healthcare infrastructure, with a budget allocation of OMR 2 billion for health services in future. These initiatives include the establishment of specialized cardiac care centers and training programs for healthcare professionals. Such efforts are expected to enhance the availability and adoption of advanced clot management devices, ultimately benefiting patient care and outcomes.
Market Challenges
High Cost of Advanced Devices: The high cost of advanced clot management devices poses a significant challenge in Oman, where healthcare spending per capita is approximately OMR 600. Many hospitals face budget constraints, limiting their ability to procure the latest technologies. This financial barrier can hinder the adoption of innovative devices, impacting patient access to effective treatment options and overall market growth. Limited Awareness Among Healthcare Professionals: There is a notable lack of awareness regarding the latest clot management technologies among healthcare professionals in Oman. A survey conducted in future indicated that only 50% of healthcare providers were familiar with the newest devices available. This knowledge gap can lead to underutilization of advanced treatment options, ultimately affecting patient outcomes and the overall effectiveness of the healthcare system.
Oman Clot Management Devices Market Future Outlook
The future of the Oman clot management devices market appears promising, driven by ongoing technological advancements and government support for healthcare improvements. As the healthcare infrastructure expands, the demand for innovative and effective treatment options is expected to rise. Additionally, the integration of artificial intelligence in medical devices is likely to enhance diagnostic accuracy and treatment efficacy, further propelling market growth. The focus on patient-centric care will also shape future developments in this sector.
Market Opportunities
Growing Demand for Minimally Invasive Procedures: There is an increasing demand for minimally invasive procedures in Oman, with a projected growth rate of 20% annually. This trend is driven by patient preferences for less invasive options that offer quicker recovery times. As a result, manufacturers of clot management devices have a significant opportunity to develop and market products that cater to this demand, enhancing patient satisfaction and outcomes. Expansion of Healthcare Infrastructure: The ongoing expansion of healthcare infrastructure in Oman, with over 15 new hospitals planned by future, presents a substantial opportunity for the clot management devices market. This growth will facilitate increased access to advanced medical technologies and improve patient care. Companies that strategically position themselves in this expanding market can capitalize on the rising demand for effective clot management solutions.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
95 Pages
- 1. Oman Clot Management Devices Size, Share, Growth Drivers, Trends, Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Oman Clot Management Devices Size, Share, Growth Drivers, Trends, Opportunities & – Market Size (in USD Bn), 2019–2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Oman Clot Management Devices Size, Share, Growth Drivers, Trends, Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1 Increasing prevalence of cardiovascular diseases in Oman
- 3.1.2 Advancements in clot management technologies
- 3.1.3 Rising healthcare expenditure and investment in medical devices
- 3.1.4 Growing awareness and education regarding clot management
- 3.2. Restraints
- 3.2.1 High cost of advanced clot management devices
- 3.2.2 Limited access to healthcare facilities in rural areas
- 3.2.3 Stringent regulatory approvals for new devices
- 3.2.4 Lack of trained healthcare professionals in certain regions
- 3.3. Opportunities
- 3.3.1 Expansion of healthcare infrastructure in Oman
- 3.3.2 Increasing collaborations between local and international companies
- 3.3.3 Development of cost-effective clot management solutions
- 3.3.4 Rising demand for minimally invasive procedures
- 3.4. Trends
- 3.4.1 Shift towards home healthcare and remote monitoring
- 3.4.2 Integration of AI and machine learning in device functionality
- 3.4.3 Growing focus on patient-centric care models
- 3.4.4 Increasing adoption of telemedicine for follow-up care
- 3.5. Government Regulation
- 3.5.1 Compliance with Oman Medical Specialty Board guidelines
- 3.5.2 Regulatory pathways for medical device approvals
- 3.5.3 Monitoring and evaluation of device performance
- 3.5.4 Policies promoting local manufacturing of medical devices
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Oman Clot Management Devices Size, Share, Growth Drivers, Trends, Opportunities & – Market Segmentation, 2024
- 4.1. By Product Type (in Value %)
- 4.1.1 Thrombectomy Devices
- 4.1.2 Stents
- 4.1.3 Catheters
- 4.1.4 Other Devices
- 4.1.5 Others
- 4.2. By Material Type (in Value %)
- 4.2.1 Metal
- 4.2.2 Polymer
- 4.2.3 Biodegradable Materials
- 4.3. By End-User (in Value %)
- 4.3.1 Hospitals
- 4.3.2 Clinics
- 4.3.3 Home Healthcare
- 4.4. By Price Tier (in Value %)
- 4.4.1 Premium
- 4.4.2 Mid-range
- 4.4.3 Economy
- 4.5. By Region (in Value %)
- 4.5.1 Muscat
- 4.5.2 Dhofar
- 4.5.3 Al Batinah
- 4.5.4 Al Dakhiliyah
- 4.5.5 Al Sharqiyah
- 4.5.6 Al Wusta
- 4.5.7 Musandam
- 5. Oman Clot Management Devices Size, Share, Growth Drivers, Trends, Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1 Medtronic
- 5.1.2 Boston Scientific
- 5.1.3 Abbott Laboratories
- 5.1.4 Terumo Corporation
- 5.1.5 B. Braun Melsungen AG
- 5.2. Cross Comparison Parameters
- 5.2.1 No. of Employees
- 5.2.2 Headquarters
- 5.2.3 Inception Year
- 5.2.4 Revenue
- 5.2.5 Production Capacity
- 6. Oman Clot Management Devices Size, Share, Growth Drivers, Trends, Opportunities & – Market Regulatory Framework
- 6.1. Medical Device Standards in Oman
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Oman Clot Management Devices Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Size (in USD Bn), 2025–2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Oman Clot Management Devices Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Segmentation, 2030
- 8.1. By Product Type (in Value %)
- 8.2. By Material Type (in Value %)
- 8.3. By End-User (in Value %)
- 8.4. By Price Tier (in Value %)
- 8.5. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
